Skip to main content

Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study

Publication ,  Conference
Magbanua, MJ; Hendrix, L; Hyslop, T; Barry, WT; Winer, EP; Hudis, C; Toppmeyer, D; Burnstein, H; Qadir, M; Ma, C; Scott, JH; Park, JW; Rugo, HS
Published in: CANCER RESEARCH
February 1, 2018

Duke Scholars

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

February 1, 2018

Volume

78

Issue

4

Location

San Antonio, TX

Publisher

AMER ASSOC CANCER RESEARCH

Conference Name

San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Magbanua, M. J., Hendrix, L., Hyslop, T., Barry, W. T., Winer, E. P., Hudis, C., … Rugo, H. S. (2018). Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study. In CANCER RESEARCH (Vol. 78). San Antonio, TX: AMER ASSOC CANCER RESEARCH.
Magbanua, Mark J., Laura Hendrix, Terry Hyslop, William T. Barry, Eric P. Winer, Clifford Hudis, Deborah Toppmeyer, et al. “Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study.” In CANCER RESEARCH, Vol. 78. AMER ASSOC CANCER RESEARCH, 2018.
Magbanua MJ, Hendrix L, Hyslop T, Barry WT, Winer EP, Hudis C, et al. Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study. In: CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2018.
Magbanua MJ, Hendrix L, Hyslop T, Barry WT, Winer EP, Hudis C, Toppmeyer D, Burnstein H, Qadir M, Ma C, Scott JH, Park JW, Rugo HS. Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2018.

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

February 1, 2018

Volume

78

Issue

4

Location

San Antonio, TX

Publisher

AMER ASSOC CANCER RESEARCH

Conference Name

San Antonio Breast Cancer Symposium

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis